0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Veterinary Immunomodulators Market Research Report 2024
Published Date: December 2024
|
Report Code: QYRE-Auto-31U18620
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Veterinary Immunomodulators Market Research Report 2024
BUY CHAPTERS

Global Veterinary Immunomodulators Market Research Report 2024

Code: QYRE-Auto-31U18620
Report
December 2024
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Veterinary Immunomodulators Market Size

The global market for Veterinary Immunomodulators was valued at US$ 1109 million in the year 2023 and is projected to reach a revised size of US$ 1625 million by 2030, growing at a CAGR of 5.6% during the forecast period.

Veterinary Immunomodulators Market

Veterinary Immunomodulators Market

Veterinary Immunomodulators are substances or drugs used to regulate or modify the immune system of animals. They are typically used in veterinary medicine to enhance or suppress the immune response in animals that are suffering from immune-related disorders or infections. Immunomodulators can help boost the animal's ability to fight infections, control autoimmune diseases, or regulate allergic reactions. They are often prescribed when an animal's immune system is either underactive (leading to infections) or overactive (leading to autoimmune or inflammatory diseases).
North American market for Veterinary Immunomodulators is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Veterinary Immunomodulators is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Veterinary Immunomodulators include Zoetis, Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, MSD Animal Health, ImmunoVet Ltd., Vetoquinol S.A., Phibro Animal Health Corporation, Ceva Santé Animale, Biogenesis Bago, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Immunomodulators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Immunomodulators.
The Veterinary Immunomodulators market size, estimations, and forecasts are provided in terms of sales volume (kg) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Veterinary Immunomodulators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Immunomodulators manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Immunomodulators Market Report

Report Metric Details
Report Name Veterinary Immunomodulators Market
Accounted market size in year US$ 1109 million
Forecasted market size in 2030 US$ 1625 million
CAGR 5.6%
Base Year year
Forecasted years 2024 - 2030
Segment by Type
Segment by Application
  • Online Sales
  • Offline Sales
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Zoetis, Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, MSD Animal Health, ImmunoVet Ltd., Vetoquinol S.A., Phibro Animal Health Corporation, Ceva Santé Animale, Biogenesis Bago
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Veterinary Immunomodulators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Veterinary Immunomodulators in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Veterinary Immunomodulators Market growing?

Ans: The Veterinary Immunomodulators Market witnessing a CAGR of 5.6% during the forecast period 2024-2030.

What is the Veterinary Immunomodulators Market size in 2030?

Ans: The Veterinary Immunomodulators Market size in 2030 will be US$ 1625 million.

Who are the main players in the Veterinary Immunomodulators Market report?

Ans: The main players in the Veterinary Immunomodulators Market are Zoetis, Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, MSD Animal Health, ImmunoVet Ltd., Vetoquinol S.A., Phibro Animal Health Corporation, Ceva Santé Animale, Biogenesis Bago

What are the Application segmentation covered in the Veterinary Immunomodulators Market report?

Ans: The Applications covered in the Veterinary Immunomodulators Market report are Online Sales, Offline Sales

What are the Type segmentation covered in the Veterinary Immunomodulators Market report?

Ans: The Types covered in the Veterinary Immunomodulators Market report are Oral, Injectable, Topical, Others

Recommended Reports

Veterinary Devices

Livestock Health

Veterinary Diagnostics

1 Veterinary Immunomodulators Market Overview
1.1 Product Definition
1.2 Veterinary Immunomodulators by Type
1.2.1 Global Veterinary Immunomodulators Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Injectable
1.2.4 Topical
1.2.5 Others
1.3 Veterinary Immunomodulators by Application
1.3.1 Global Veterinary Immunomodulators Market Value by Application (2024-2030)
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Global Veterinary Immunomodulators Market Size Estimates and Forecasts
1.4.1 Global Veterinary Immunomodulators Revenue 2019-2030
1.4.2 Global Veterinary Immunomodulators Sales 2019-2030
1.4.3 Global Veterinary Immunomodulators Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Veterinary Immunomodulators Market Competition by Manufacturers
2.1 Global Veterinary Immunomodulators Sales Market Share by Manufacturers (2019-2024)
2.2 Global Veterinary Immunomodulators Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Veterinary Immunomodulators Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Veterinary Immunomodulators, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Veterinary Immunomodulators, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Veterinary Immunomodulators, Product Type & Application
2.7 Global Key Manufacturers of Veterinary Immunomodulators, Date of Enter into This Industry
2.8 Global Veterinary Immunomodulators Market Competitive Situation and Trends
2.8.1 Global Veterinary Immunomodulators Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Veterinary Immunomodulators Players Market Share by Revenue
2.8.3 Global Veterinary Immunomodulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Veterinary Immunomodulators Market Scenario by Region
3.1 Global Veterinary Immunomodulators Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Veterinary Immunomodulators Sales by Region: 2019-2030
3.2.1 Global Veterinary Immunomodulators Sales by Region: 2019-2024
3.2.2 Global Veterinary Immunomodulators Sales by Region: 2025-2030
3.3 Global Veterinary Immunomodulators Revenue by Region: 2019-2030
3.3.1 Global Veterinary Immunomodulators Revenue by Region: 2019-2024
3.3.2 Global Veterinary Immunomodulators Revenue by Region: 2025-2030
3.4 North America Veterinary Immunomodulators Market Facts & Figures by Country
3.4.1 North America Veterinary Immunomodulators Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Veterinary Immunomodulators Sales by Country (2019-2030)
3.4.3 North America Veterinary Immunomodulators Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Veterinary Immunomodulators Market Facts & Figures by Country
3.5.1 Europe Veterinary Immunomodulators Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Veterinary Immunomodulators Sales by Country (2019-2030)
3.5.3 Europe Veterinary Immunomodulators Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Veterinary Immunomodulators Market Facts & Figures by Region
3.6.1 Asia Pacific Veterinary Immunomodulators Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Veterinary Immunomodulators Sales by Region (2019-2030)
3.6.3 Asia Pacific Veterinary Immunomodulators Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Veterinary Immunomodulators Market Facts & Figures by Country
3.7.1 Latin America Veterinary Immunomodulators Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Veterinary Immunomodulators Sales by Country (2019-2030)
3.7.3 Latin America Veterinary Immunomodulators Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Veterinary Immunomodulators Market Facts & Figures by Country
3.8.1 Middle East and Africa Veterinary Immunomodulators Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Veterinary Immunomodulators Sales by Country (2019-2030)
3.8.3 Middle East and Africa Veterinary Immunomodulators Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Veterinary Immunomodulators Sales by Type (2019-2030)
4.1.1 Global Veterinary Immunomodulators Sales by Type (2019-2024)
4.1.2 Global Veterinary Immunomodulators Sales by Type (2025-2030)
4.1.3 Global Veterinary Immunomodulators Sales Market Share by Type (2019-2030)
4.2 Global Veterinary Immunomodulators Revenue by Type (2019-2030)
4.2.1 Global Veterinary Immunomodulators Revenue by Type (2019-2024)
4.2.2 Global Veterinary Immunomodulators Revenue by Type (2025-2030)
4.2.3 Global Veterinary Immunomodulators Revenue Market Share by Type (2019-2030)
4.3 Global Veterinary Immunomodulators Price by Type (2019-2030)
5 Segment by Application
5.1 Global Veterinary Immunomodulators Sales by Application (2019-2030)
5.1.1 Global Veterinary Immunomodulators Sales by Application (2019-2024)
5.1.2 Global Veterinary Immunomodulators Sales by Application (2025-2030)
5.1.3 Global Veterinary Immunomodulators Sales Market Share by Application (2019-2030)
5.2 Global Veterinary Immunomodulators Revenue by Application (2019-2030)
5.2.1 Global Veterinary Immunomodulators Revenue by Application (2019-2024)
5.2.2 Global Veterinary Immunomodulators Revenue by Application (2025-2030)
5.2.3 Global Veterinary Immunomodulators Revenue Market Share by Application (2019-2030)
5.3 Global Veterinary Immunomodulators Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis, Inc.
6.1.1 Zoetis, Inc. Company Information
6.1.2 Zoetis, Inc. Description and Business Overview
6.1.3 Zoetis, Inc. Veterinary Immunomodulators Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis, Inc. Veterinary Immunomodulators Product Portfolio
6.1.5 Zoetis, Inc. Recent Developments/Updates
6.2 Elanco Animal Health
6.2.1 Elanco Animal Health Company Information
6.2.2 Elanco Animal Health Description and Business Overview
6.2.3 Elanco Animal Health Veterinary Immunomodulators Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Elanco Animal Health Veterinary Immunomodulators Product Portfolio
6.2.5 Elanco Animal Health Recent Developments/Updates
6.3 Boehringer Ingelheim Animal Health
6.3.1 Boehringer Ingelheim Animal Health Company Information
6.3.2 Boehringer Ingelheim Animal Health Description and Business Overview
6.3.3 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product Portfolio
6.3.5 Boehringer Ingelheim Animal Health Recent Developments/Updates
6.4 MSD Animal Health
6.4.1 MSD Animal Health Company Information
6.4.2 MSD Animal Health Description and Business Overview
6.4.3 MSD Animal Health Veterinary Immunomodulators Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MSD Animal Health Veterinary Immunomodulators Product Portfolio
6.4.5 MSD Animal Health Recent Developments/Updates
6.5 ImmunoVet Ltd.
6.5.1 ImmunoVet Ltd. Company Information
6.5.2 ImmunoVet Ltd. Description and Business Overview
6.5.3 ImmunoVet Ltd. Veterinary Immunomodulators Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ImmunoVet Ltd. Veterinary Immunomodulators Product Portfolio
6.5.5 ImmunoVet Ltd. Recent Developments/Updates
6.6 Vetoquinol S.A.
6.6.1 Vetoquinol S.A. Company Information
6.6.2 Vetoquinol S.A. Description and Business Overview
6.6.3 Vetoquinol S.A. Veterinary Immunomodulators Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Vetoquinol S.A. Veterinary Immunomodulators Product Portfolio
6.6.5 Vetoquinol S.A. Recent Developments/Updates
6.7 Phibro Animal Health Corporation
6.7.1 Phibro Animal Health Corporation Company Information
6.7.2 Phibro Animal Health Corporation Description and Business Overview
6.7.3 Phibro Animal Health Corporation Veterinary Immunomodulators Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Phibro Animal Health Corporation Veterinary Immunomodulators Product Portfolio
6.7.5 Phibro Animal Health Corporation Recent Developments/Updates
6.8 Ceva Santé Animale
6.8.1 Ceva Santé Animale Company Information
6.8.2 Ceva Santé Animale Description and Business Overview
6.8.3 Ceva Santé Animale Veterinary Immunomodulators Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ceva Santé Animale Veterinary Immunomodulators Product Portfolio
6.8.5 Ceva Santé Animale Recent Developments/Updates
6.9 Biogenesis Bago
6.9.1 Biogenesis Bago Company Information
6.9.2 Biogenesis Bago Description and Business Overview
6.9.3 Biogenesis Bago Veterinary Immunomodulators Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biogenesis Bago Veterinary Immunomodulators Product Portfolio
6.9.5 Biogenesis Bago Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Veterinary Immunomodulators Industry Chain Analysis
7.2 Veterinary Immunomodulators Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Veterinary Immunomodulators Production Mode & Process
7.4 Veterinary Immunomodulators Sales and Marketing
7.4.1 Veterinary Immunomodulators Sales Channels
7.4.2 Veterinary Immunomodulators Distributors
7.5 Veterinary Immunomodulators Customers
8 Veterinary Immunomodulators Market Dynamics
8.1 Veterinary Immunomodulators Industry Trends
8.2 Veterinary Immunomodulators Market Drivers
8.3 Veterinary Immunomodulators Market Challenges
8.4 Veterinary Immunomodulators Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Veterinary Immunomodulators Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Veterinary Immunomodulators Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Veterinary Immunomodulators Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Veterinary Immunomodulators Sales (kg) of Key Manufacturers (2019-2024)
 Table 5. Global Veterinary Immunomodulators Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Veterinary Immunomodulators Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Veterinary Immunomodulators Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Veterinary Immunomodulators Average Price (US$/g) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Veterinary Immunomodulators, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Veterinary Immunomodulators, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Veterinary Immunomodulators, Product Type & Application
 Table 12. Global Key Manufacturers of Veterinary Immunomodulators, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Veterinary Immunomodulators by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Immunomodulators as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Veterinary Immunomodulators Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Veterinary Immunomodulators Sales by Region (2019-2024) & (kg)
 Table 18. Global Veterinary Immunomodulators Sales Market Share by Region (2019-2024)
 Table 19. Global Veterinary Immunomodulators Sales by Region (2025-2030) & (kg)
 Table 20. Global Veterinary Immunomodulators Sales Market Share by Region (2025-2030)
 Table 21. Global Veterinary Immunomodulators Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Veterinary Immunomodulators Revenue Market Share by Region (2019-2024)
 Table 23. Global Veterinary Immunomodulators Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Veterinary Immunomodulators Revenue Market Share by Region (2025-2030)
 Table 25. North America Veterinary Immunomodulators Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Veterinary Immunomodulators Sales by Country (2019-2024) & (kg)
 Table 27. North America Veterinary Immunomodulators Sales by Country (2025-2030) & (kg)
 Table 28. North America Veterinary Immunomodulators Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Veterinary Immunomodulators Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Veterinary Immunomodulators Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Veterinary Immunomodulators Sales by Country (2019-2024) & (kg)
 Table 32. Europe Veterinary Immunomodulators Sales by Country (2025-2030) & (kg)
 Table 33. Europe Veterinary Immunomodulators Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Veterinary Immunomodulators Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Veterinary Immunomodulators Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Veterinary Immunomodulators Sales by Region (2019-2024) & (kg)
 Table 37. Asia Pacific Veterinary Immunomodulators Sales by Region (2025-2030) & (kg)
 Table 38. Asia Pacific Veterinary Immunomodulators Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Veterinary Immunomodulators Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Veterinary Immunomodulators Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Veterinary Immunomodulators Sales by Country (2019-2024) & (kg)
 Table 42. Latin America Veterinary Immunomodulators Sales by Country (2025-2030) & (kg)
 Table 43. Latin America Veterinary Immunomodulators Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Veterinary Immunomodulators Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Veterinary Immunomodulators Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Veterinary Immunomodulators Sales by Country (2019-2024) & (kg)
 Table 47. Middle East and Africa Veterinary Immunomodulators Sales by Country (2025-2030) & (kg)
 Table 48. Middle East and Africa Veterinary Immunomodulators Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Veterinary Immunomodulators Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Veterinary Immunomodulators Sales (kg) by Type (2019-2024)
 Table 51. Global Veterinary Immunomodulators Sales (kg) by Type (2025-2030)
 Table 52. Global Veterinary Immunomodulators Sales Market Share by Type (2019-2024)
 Table 53. Global Veterinary Immunomodulators Sales Market Share by Type (2025-2030)
 Table 54. Global Veterinary Immunomodulators Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Veterinary Immunomodulators Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Veterinary Immunomodulators Revenue Market Share by Type (2019-2024)
 Table 57. Global Veterinary Immunomodulators Revenue Market Share by Type (2025-2030)
 Table 58. Global Veterinary Immunomodulators Price (US$/g) by Type (2019-2024)
 Table 59. Global Veterinary Immunomodulators Price (US$/g) by Type (2025-2030)
 Table 60. Global Veterinary Immunomodulators Sales (kg) by Application (2019-2024)
 Table 61. Global Veterinary Immunomodulators Sales (kg) by Application (2025-2030)
 Table 62. Global Veterinary Immunomodulators Sales Market Share by Application (2019-2024)
 Table 63. Global Veterinary Immunomodulators Sales Market Share by Application (2025-2030)
 Table 64. Global Veterinary Immunomodulators Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Veterinary Immunomodulators Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Veterinary Immunomodulators Revenue Market Share by Application (2019-2024)
 Table 67. Global Veterinary Immunomodulators Revenue Market Share by Application (2025-2030)
 Table 68. Global Veterinary Immunomodulators Price (US$/g) by Application (2019-2024)
 Table 69. Global Veterinary Immunomodulators Price (US$/g) by Application (2025-2030)
 Table 70. Zoetis, Inc. Company Information
 Table 71. Zoetis, Inc. Description and Business Overview
 Table 72. Zoetis, Inc. Veterinary Immunomodulators Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 73. Zoetis, Inc. Veterinary Immunomodulators Product
 Table 74. Zoetis, Inc. Recent Developments/Updates
 Table 75. Elanco Animal Health Company Information
 Table 76. Elanco Animal Health Description and Business Overview
 Table 77. Elanco Animal Health Veterinary Immunomodulators Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 78. Elanco Animal Health Veterinary Immunomodulators Product
 Table 79. Elanco Animal Health Recent Developments/Updates
 Table 80. Boehringer Ingelheim Animal Health Company Information
 Table 81. Boehringer Ingelheim Animal Health Description and Business Overview
 Table 82. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 83. Boehringer Ingelheim Animal Health Veterinary Immunomodulators Product
 Table 84. Boehringer Ingelheim Animal Health Recent Developments/Updates
 Table 85. MSD Animal Health Company Information
 Table 86. MSD Animal Health Description and Business Overview
 Table 87. MSD Animal Health Veterinary Immunomodulators Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 88. MSD Animal Health Veterinary Immunomodulators Product
 Table 89. MSD Animal Health Recent Developments/Updates
 Table 90. ImmunoVet Ltd. Company Information
 Table 91. ImmunoVet Ltd. Description and Business Overview
 Table 92. ImmunoVet Ltd. Veterinary Immunomodulators Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 93. ImmunoVet Ltd. Veterinary Immunomodulators Product
 Table 94. ImmunoVet Ltd. Recent Developments/Updates
 Table 95. Vetoquinol S.A. Company Information
 Table 96. Vetoquinol S.A. Description and Business Overview
 Table 97. Vetoquinol S.A. Veterinary Immunomodulators Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 98. Vetoquinol S.A. Veterinary Immunomodulators Product
 Table 99. Vetoquinol S.A. Recent Developments/Updates
 Table 100. Phibro Animal Health Corporation Company Information
 Table 101. Phibro Animal Health Corporation Description and Business Overview
 Table 102. Phibro Animal Health Corporation Veterinary Immunomodulators Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 103. Phibro Animal Health Corporation Veterinary Immunomodulators Product
 Table 104. Phibro Animal Health Corporation Recent Developments/Updates
 Table 105. Ceva Santé Animale Company Information
 Table 106. Ceva Santé Animale Description and Business Overview
 Table 107. Ceva Santé Animale Veterinary Immunomodulators Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 108. Ceva Santé Animale Veterinary Immunomodulators Product
 Table 109. Ceva Santé Animale Recent Developments/Updates
 Table 110. Biogenesis Bago Company Information
 Table 111. Biogenesis Bago Description and Business Overview
 Table 112. Biogenesis Bago Veterinary Immunomodulators Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
 Table 113. Biogenesis Bago Veterinary Immunomodulators Product
 Table 114. Biogenesis Bago Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Veterinary Immunomodulators Distributors List
 Table 118. Veterinary Immunomodulators Customers List
 Table 119. Veterinary Immunomodulators Market Trends
 Table 120. Veterinary Immunomodulators Market Drivers
 Table 121. Veterinary Immunomodulators Market Challenges
 Table 122. Veterinary Immunomodulators Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Veterinary Immunomodulators
 Figure 2. Global Veterinary Immunomodulators Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Veterinary Immunomodulators Market Share by Type: 2023 & 2030
 Figure 4. Oral Product Picture
 Figure 5. Injectable Product Picture
 Figure 6. Topical Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Veterinary Immunomodulators Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global Veterinary Immunomodulators Market Share by Application: 2023 & 2030
 Figure 10. Online Sales
 Figure 11. Offline Sales
 Figure 12. Global Veterinary Immunomodulators Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Veterinary Immunomodulators Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Veterinary Immunomodulators Sales (2019-2030) & (kg)
 Figure 15. Global Veterinary Immunomodulators Average Price (US$/g) & (2019-2030)
 Figure 16. Veterinary Immunomodulators Report Years Considered
 Figure 17. Veterinary Immunomodulators Sales Share by Manufacturers in 2023
 Figure 18. Global Veterinary Immunomodulators Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Veterinary Immunomodulators Players: Market Share by Revenue in Veterinary Immunomodulators in 2023
 Figure 20. Veterinary Immunomodulators Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Veterinary Immunomodulators Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Veterinary Immunomodulators Sales Market Share by Country (2019-2030)
 Figure 23. North America Veterinary Immunomodulators Revenue Market Share by Country (2019-2030)
 Figure 24. United States Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Veterinary Immunomodulators Sales Market Share by Country (2019-2030)
 Figure 27. Europe Veterinary Immunomodulators Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Veterinary Immunomodulators Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Veterinary Immunomodulators Revenue Market Share by Region (2019-2030)
 Figure 35. China Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Veterinary Immunomodulators Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Veterinary Immunomodulators Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Veterinary Immunomodulators Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Veterinary Immunomodulators Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Veterinary Immunomodulators by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Veterinary Immunomodulators by Type (2019-2030)
 Figure 54. Global Veterinary Immunomodulators Price (US$/g) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Veterinary Immunomodulators by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Veterinary Immunomodulators by Application (2019-2030)
 Figure 57. Global Veterinary Immunomodulators Price (US$/g) by Application (2019-2030)
 Figure 58. Veterinary Immunomodulators Value Chain
 Figure 59. Veterinary Immunomodulators Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD